Schizophrenia tied to higher risk for severe COVID-19

Schizophrenia tied to higher risk for severe COVID-19

(HealthDay)—Individuals with schizophrenia are at increased risk for COVID-19 morbidity and mortality versus individuals without schizophrenia, according to a study published in the September issue of Schizophrenia Bulletin.

Dana Tzur Bitan, Ph.D., from Ariel University in Israel, and colleagues explored the odds of significant COVID-19 morbidity and mortality among patients with schizophrenia. The analysis included 51,078 patients with schizophrenia and age- and sex-matched controls (25,539 in each group).

The researchers found that individuals with schizophrenia were less likely to test positive for COVID-19; however, they were twice as likely to be hospitalized for COVID-19 (odds ratio, 2.15), even after controlling for sociodemographic and clinical risk factors (adjusted odds ratio, 1.88). Additionally, patients with schizophrenia were three times more likely to experience COVID-19 mortality (odds ratio, 3.27) compared with the control group.

Source: Read Full Article

Related posts:
  1. Low nurse and support staffing tied to higher inpatient mortality
  2. Common heartburn drugs may be tied to higher COVID risk
  3. Exposure to Maternal Gestational Diabetes Tied to Higher CVD Risk
  4. Food Insecurity Tied to Higher Cardiovascular Mortality
  5. Implementation science should give higher priority to health equity